From CFTR to a CF signalling network: a systems biology approach to study Cystic Fibrosis
Cystic Fibrosis (CF) is a monogenic disease caused by mutations in the gene coding the Cystic Fibrosis Transmembrane Regulator (CFTR) protein, but its overall physio-pathology cannot be solely explained by the loss of the CFTR chloride channel function. Indeed, CFTR belongs to a yet not fully deciphered network of proteins participating in various signalling pathways. We propose a systems biology approach to study how the absence of the CFTR protein at the membrane leads to perturbation of these pathways, resulting in a panel of deleterious CF cellular phenotypes. Based on publicly available transcriptomic datasets, we built and analyzed a CF network that recapitulates signalling dysregulations. The CF network topology and its resulting phenotypes were found to be consistent with CF pathology. Analysis of the network topology highlighted a few proteins that may initiate the propagation of dysregulations, those that trigger CF cellular phenotypes, and suggested several candidate therapeutic targets. Although our research is focused on CF, the global approach proposed in the present paper could also be followed to study other rare monogenic diseases.
Authors
- Mairead Kelly (ORCID: https://orcid.org/0000-0001-8729-6948)
- Isabelle Sermet‐Gaudelus (ORCID: https://orcid.org/0000-0001-5537-9482)
- Matthieu Najm (ORCID: https://orcid.org/0000-0001-9757-1499)
- Véronique Stoven (ORCID: https://orcid.org/0000-0003-0828-0759)
- Matthieu Cornet (ORCID: https://orcid.org/0000-0001-5466-9373)
- Laurence Calzone (ORCID: https://orcid.org/0000-0002-7835-1148)
- Loredana Martignetti (ORCID: https://orcid.org/0000-0003-1535-7515)
Institutions
- Hôpital Necker-Enfants Malades (FR)
- Inserm (FR)
- Université Paris Cité (FR)
- Université Paris Sciences et Lettres (FR)
- Institut Necker Enfants Malades (FR)
- Sorbonne Paris Cité (FR)
- Assistance Publique – Hôpitaux de Paris (FR)
- Institut Curie (FR)
Publication Details
- Journal
- BMC Genomics
- Published
- 2024-09-28
- DOI
- https://doi.org/10.1186/s12864-024-10752-x
- Citations
- 2
- Primary Topic
- Cystic Fibrosis Research Advances
- Type
- article
- Field-Weighted Citation Impact
- 0.84
Funders
- Fondation Maladies Rares
- Fondation pour la Recherche Médicale
- Association Vaincre la Mucoviscidose
- Dassault Systèmes La Fondation
- MSDAVENIR